1. CHMP meeting: six medicines approved

   News item 30 October 2021 Pages: 1 - 1

2. One lot of Daptomycin for Injection recalled due to glass particles

   News item 30 October 2021 Pages: 2 - 2

3. One lot of methocarbamol recalled due to mislabelling of strength

   News item 30 October 2021 Pages: 3 - 3

4. PMDA revises precautions for three drugs in Japan

   News item 30 October 2021 Pages: 4 - 4

5. Teligent recalls five lots of lidocaine topical solution due to potency

   News item 30 October 2021 Pages: 5 - 5

6. Adverse drug reactions in end-stage HF patients on continuous morphine infusions in Japan

   Clinical study 30 October 2021 Pages: 6 - 6

7. Antipsychotic-related fatal poisoning in England and Wales

   Clinical study 30 October 2021 Pages: 7 - 7

8. Dronedarone + DOACs: risk of major bleeding

   Clinical study 30 October 2021 Pages: 8 - 8

9. Potential severe drug-drug interactions in elderly patients

   Clinical study 30 October 2021 Pages: 9 - 9

10. Ruxolitinib increases risk of squamous cell cancer

    Clinical study 30 October 2021 Pages: 10 - 10

11. Tramadol increases risk of all-cause mortality versus codeine

    Clinical study 30 October 2021 Pages: 11 - 11

12. Other adverse reaction research

    News item 30 October 2021 Pages: 12 - 12

13. Abatacept

    Case report 30 October 2021 Pages: 13 - 13

14. Abatacept/methotrexate/prednisolone

    Case report 30 October 2021 Pages: 14 - 14

15. Acetylcholine

    Case report 30 October 2021 Pages: 15 - 15

16. Ad26.cov2-s

    Case report 30 October 2021 Pages: 16 - 16

17. Adalimumab/methotrexate

    Case report 30 October 2021 Pages: 17 - 17

18. Adenosine

    Case report 30 October 2021 Pages: 18 - 18

19. Adenosine

    Case report 30 October 2021 Pages: 19 - 19

20. Aflibercept/brolucizumab/ranibizumab

    Case report 30 October 2021 Pages: 20 - 20

21. Aflibercept/ranibizumab

    Case report 30 October 2021 Pages: 21 - 21

22. Alectinib/bevacizumab/docetaxel

    Case report 30 October 2021 Pages: 22 - 22

23. Alemtuzumab/dexamethasone/etoposide

    Case report 30 October 2021 Pages: 23 - 23

24. Allopurinol/dapsone

    Case report 30 October 2021 Pages: 24 - 24

25. Alteplase

    Case report 30 October 2021 Pages: 25 - 25

26. Amiodarone

    Case report 30 October 2021 Pages: 26 - 26

27. Amiodarone/lidocaine

    Case report 30 October 2021 Pages: 27 - 27

28. Amlodipine overdose

    Case report 30 October 2021 Pages: 28 - 28

29. Amlodipine/hydroxyzine overdose

    Case report 30 October 2021 Pages: 29 - 29

30. Amoxicillin/clavulanic acid/fluticasone propionate/prednisone

    Case report 30 October 2021 Pages: 30 - 30

31. Amphotericin-B-liposomal

    Case report 30 October 2021 Pages: 31 - 31

32. Amphotericin-B-liposomal/posaconazole

    Case report 30 October 2021 Pages: 32 - 32

33. Amphotericin-B/amphotericin-B-liposomal/immunosuppressants

    Case report 30 October 2021 Pages: 33 - 33

34. Amphotericin-b/fluconazole

    Case report 30 October 2021 Pages: 34 - 34

35. Anakinra

    Case report 30 October 2021 Pages: 35 - 35

36. Anakinra/canakinumab

    Case report 30 October 2021 Pages: 36 - 36

37. Anakinra\Convalescent-anti-SARS-CoV-2-plasma\dexamethasone

    Case report 30 October 2021 Pages: 37 - 37

38. Antibacterials/antituberculars

    Case report 30 October 2021 Pages: 38 - 38

39. Anticoagulants/aspirin/plasminogen activators

    Case report 30 October 2021 Pages: 39 - 39

40. Antidepressants

    Case report 30 October 2021 Pages: 40 - 40

41. Antiepileptic drugs

    Case report 30 October 2021 Pages: 41 - 41

42. Antifungals/ibrutinib

    Case report 30 October 2021 Pages: 42 - 42

43. Antineoplastics

    Case report 30 October 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 30 October 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 30 October 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 30 October 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 30 October 2021 Pages: 47 - 47

48. Antineoplastics/immunosuppressants/octreotide

    Case report 30 October 2021 Pages: 48 - 48

49. Antineoplastics/metronidazole/vancomycin

    Case report 30 October 2021 Pages: 49 - 49

50. Antineoplastics/streptozocin

    Case report 30 October 2021 Pages: 50 - 50